30 years of scientific excellence
For three decades, Syngene has been dedicated to exploring the boundaries of science.
Our focus is on developing solutions that enhance human and animal health and advancing the creation of next-generation materials.
Our company’s financial performance was resilient for the fiscal year ending March 31, 2024. Revenue from operations was up 9% to Rs 3,489 Cr (USD 418 Mn) resulting in profit after tax, before exceptional items, up 12% to Rs 519 Cr (USD 62 Mn).
Read MoreFor three decades, our skilled scientists have used the latest technology to push the boundaries of innovation and deliver impactful solutions for clients to enable them to achieve more targeted results, faster, at reduced cost.
Read More
Our robust business model, diversified across the CRO and CDMO segments, coupled with a sharp focus on execution, facilitated the achievement of key strategic objectives.
Read MoreStrategy
Provide end-to-end discovery and preclinical development capabilities, on a contract basis, including differentiating research technologies and platforms, across many disease areas and therapeutic modalities
Read MoreOur Business
We are an integrated research, development and manufacturing organization providing scientific services from early discovery to commercial supply. We serve a wide range of industrial sectors including pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical companies.
Read MoreSignificant strides were made on our growth and innovation journey with the addition of world-class capabilities and enhanced capacity to support the scale and diversity of our research activities.
Driven by a shared vision of improving patient health, our dedicated research centers consistently earn recognition from clients for their role in advancing innovation.
Our focus on a range of modalities with state-of-the-art oligonucleotide and High Potent API GMP manufacturing facilities further sets us apart as a preferred development partner for therapeutic categories in small molecules.
Our state-of-the-art manufacturing services seamlessly integrate scale with bespoke solutions, prioritizing quality at every step of the way.
